Nuvo Pharmaceuticals v. Dr. Reddy’s Laboratories: Nonobvious Pharmaceutical Formulation Must Be Demonstrated
Aug 14th, 2019 by Frederick Spaeth | Patent Related Court Rulings | Patent Trends & Activity |
In Nuvo Pharmaceuticals v. Dr. Reddy’s Laboratories (Fed. Cir. 2019), the Federal Circuit held that a patent on a claimed pharmaceutical formulation was invalid for having an inadequate written description, even though the patent disclosed, in sufficient detail, effective formulations.